SCHEMBL730070

SCHEMBL730070

Brc1cc2ccc3cccc4ccc(c1)c2c34

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
HSD17B10 Q99714 5/20 0.61
TSHR P16473 5/20 0.61
HPGD P15428 4/20 0.61
CYP1B1 Q16678 3/20 0.61
CYP1A2 P05177 3/20 0.61
CYP3A4 P08684 3/20 0.61
CYP1A1 P04798 2/20 0.61
CYP2A6 P11509 1/20 0.52
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ERBB2 P04626 1/20 0.48
FYN P06241 1/20 0.48
MAOA P21397 1/20 0.48
ACHE P22303 1/20 0.48
AHR P35869 1/20 0.48
TDP1 Q9NUW8 2/20 0.45
KDM4E B2RXH2 2/20 0.45
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1445635 0.88 CYP2A6 (0.48) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL5379623 0.83 CYP1A2 (0.50) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL27671350 0.80 CYP1A2 (0.47) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL18117630 0.80 CYP2A6 (0.40) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL31598684 0.80 CYP2A6 (0.40) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL30867671 0.79 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL40362 0.79 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL29555052 0.79 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL106821 0.79 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1B1
SCHEMBL29524698 0.79 ALDH1A1 (0.73) ALDH1A1HSD17B10TSHRHPGDCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117747174-A Anti-radiation wire and preparation method thereof 新凝合科技(成都)有限公司 2024-03-22 CN claimed
EP-3478652-B1 ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE BOE TECHNOLOGY GROUP CO LTD (CN) 2024-02-07 EP claimed
CN-115785444-A Inert polyarylene sulfide with aromatic ring as end group, and preparation method and application thereof 中鼎凯瑞科技成都有限公司 2023-03-14 CN claimed
CN-109280011-B Synthesis method of OLED intermediate 2-bromopyrene 棓诺(苏州)新材料有限公司 2021-06-11 CN claimed
CN-109280011-A The synthetic method of OLED intermediate 2- bromine pyrene 棓诺(苏州)新材料有限公司 2019-01-29 CN claimed
US-20250223491-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2025-07-10 US disclosed
CN-120058659-A Aromatic amine compound, organic electroluminescent element and electronic equipment 海宁奕诺炜特科技有限公司 2025-05-30 CN disclosed
CN-120058535-A Aromatic amine compound, organic electroluminescent element and electronic equipment 海宁奕诺炜特科技有限公司 2025-05-30 CN disclosed
CN-119264141-B Anthrazepine material and preparation method and application thereof 烟台九目化学股份有限公司 2025-02-14 CN disclosed
EP-4497750-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME Solus Advanced Materials Co., Ltd. (KR) 2025-01-29 EP disclosed
CN-119264141-A Anthrazepine material and preparation method and application thereof 烟台九目化学股份有限公司 2025-01-07 CN disclosed
US-12173209-B2 Quantum dot, and ink composition, light-emitting device, optical member, and apparatus including quantum dot SAMSUNG DISPLAY CO., LTD. (KR) 2024-12-24 US disclosed
WO-2007022263-A1 FLUOROGENIC PROBES FOR MEDIUM CHAIN ACYL-COA DEHYDROGENASE ( MCAD ) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2007-02-22 WO disclosed
US-20060115678-A1 Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2006-06-01 US disclosed
EP-1594855-A2 SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE LUMIGEN, INC. (US) 2005-11-16 EP disclosed
US-6919463-B2 Signalling compounds for use in methods of detecting hydrogen peroxide LUMIGEN, INC. (US) 2005-07-19 US disclosed
EP-1506959-A2 Derivatised molecules for mass spectrometry OXFORD GENE TECHNOLOGY IP LIMITED (GB) 2005-02-16 EP disclosed
WO-2004074810-A2 SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE LUMIGEN INC. (US) 2004-09-02 WO disclosed
US-20040171098-A1 Signalling compounds for use in methods of detecting hydrogen peroxide LUMIGEN INC. 2004-09-02 US disclosed
US-20040166539-A1 Signalling compounds and methods for detecting hydrogen peroxide LUMIGEN, INC. 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060115678-A1 Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device ALAD, PAH, PPOX ALDH1A1 697/4885HSD17B10 2743/4885TSHR 4167/4885
US-20040171098-A1 Signalling compounds for use in methods of detecting hydrogen peroxide LPO, HAO2, HAO1 ALDH1A1 252/4885HSD17B10 63/4885TSHR 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.